FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.

Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.

the company has secured a substantial Purchase Order worth Rs 17.64 Crores for supplying 1 KW HF and SATCOM Equipment, with the contract formalized on November 1, 2023. The esteemed client for this deal is M/s. Cochin Shipyard Limited.

Additionally, another notable Purchase Order, valued at Rs 1.61 Crore, has been received for Automatic Test Equipment (ATE) dedicated to Radar Equipment. This contract was also confirmed on November 1, 2023, with Satish Dhawan Space Centre – SHAR, ISRO, as the client.

GE T&D India Ltd's Strong Market Position , Ability to Deliver Quality Products and Receipt of Orders from PGC

So far 14 lakh cars sold since inception.

The company announced Q3FY23 results wherein the company recorded the highest sales of 91,232 thousand tonnes vs 65,088 thousand tonnes in Q3FY22, a growth of 40per cent YoY.

The stock delivered a multibagger return of 135.38 per cent in just six months, while the BSE Sensex gained only 17.84 per cent.

The stock delivered a multi-bagger return of 112 per cent in just six months, while the BSE Sensex gained only 19 per cent. In addition, the stock has gained 93 per cent year to date.

The annual report has all the information of the company and here we will look at important sections to be read in an annual report. 

Stock has given staggering 68 per cent returns in less than a month of its listing. Sales has doubled in past three years.

So, let’s know the reason behind this wide-margin outperformance in such a slippery market condition.